Lachlan Brown

Stock Analyst at William Blair

(2.32)
# 2,589
Out of 5,128 analysts
11
Total ratings
44.44%
Success rate
14.08%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $30.72
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $168.81
Upside: +18.48%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $53.50
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $8.26
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $11.25
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $508.77
Upside: +17.93%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $314.64
Upside: +11.24%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $23.94
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $85.52
Upside: +5.24%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $91.47
Upside: +140.52%